Formulation of Superparamagnetic Iron Oxides by Nanoparticles of Biodegradable Polymers for Magnetic Resonance Imaging
- 24 January 2008
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 18 (2) , 308-318
Abstract
A system of poly(lactide‐co‐glycolide)‐methoxy poly(ethylene glycol) (PLGA‐mPEG) nanoparticles is developed to formulate superparamagnetic iron oxides (IOs) for magnetic resonance imaging (MRI). This system improves the imaging effects, increases the half‐life of the IOs in circulation, and reduces their side effects. The IO‐loaded PLGA‐mPEG nanoparticles were prepared by a modified water‐in‐oil‐in‐water double‐emulsion technique. Their physicochemical and superparamagnetic properties were characterized by various techniques. In vitro IO release kinetics from the nanoparticles and stability of the IO‐loaded polymeric nanoparticles were also investigated. In vitro and ex vivo MRI of the IOs formulated in the PLGA‐mPEG nanoparticles show that the saturation magnetization and the r2, r2* relaxivities are enhanced, and the contrast effects are improved in comparison with commercial IOs (Resovist). It is proven that the enhanced superparamagnetic properties are caused by the polymeric nanoparticle formulation but not by the polymeric material itself. Moreover, the PLGA‐mPEG nanoparticle formulation achieves 36.9 and 35.6 % less cytotoxicity in comparison with the IOs (Resovist) after 48 h incubation at the same 20 and 50 μg mL–1 Fe concentration, respectively. This research implies that formulation of IOs by nanoparticles of PLGA‐mPEG copolymer or other biodegradable polymers could be promising for more effective and sustainable MRI with reduced side effects, which, with targeting probes conjugated to the nanoparticle surface, can be further used to promote cellular and molecular MRI.Keywords
This publication has 41 references indexed in Scilit:
- Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug deliveryBiomaterials, 2007
- Annexin A5-Functionalized Bimodal Lipid-Based Contrast Agents for the Detection of ApoptosisBioconjugate Chemistry, 2006
- Nanoparticles of poly(D,L‐lactide)/methoxy poly(ethylene glycol)‐poly(D,L‐lactide) blends for controlled release of paclitaxelJournal of Biomedical Materials Research Part A, 2006
- Composite magnetic particles: 2. Encapsulation of iron oxide by surfactant-free emulsion polymerizationPolymer, 2005
- Synthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials, 2005
- Intracellular translocation of superparamagnetic iron oxide nanoparticles encapsulated with peptide-conjugated poly(D,L lactide-co-glycolide)Journal of Applied Physics, 2005
- Magnetic Properties of Fe$_3$O$_4$Nanoparticles Encapsulated With Poly(D,L Lactide-Co-Glycolide)IEEE Transactions on Magnetics, 2004
- Contrast Agents for Magnetic Resonance ImagingTopics in Magnetic Resonance Imaging, 2003
- The preparation of magnetic nanoparticles for applications in biomedicineJournal of Physics D: Applied Physics, 2003
- Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticlesInternational Journal of Pharmaceutics, 1996